Peter Young Email & Phone Number

Piermont Ny

Providing a range of strategic, business, and management consulting advice and support to life science companies and organizations.

Advancing novel, proprietary oral peptide formulation and peptide discovery technology to capitalize on product opportunities in musculoskeletal diseases like osteoporosis, arthritis, and rheumatoid arthritis.

Consolidated and focused the company on a promising specialty pharmaceutical product leading to a global deal and exit.

Served as an independent director and member of the audit committee.

Member of Vaccine and Intellectual Property Committees

Advanced a highly innovative viral vector vaccine platform from the research bench to the clinic, leveraging over $80 million in peer-reviewed product development grant funding and including biosafety-level 3 R&D and GMP manufacturing facilities.

Global development, registration, launch & roll-out of Glaxo Wellcome's transformational HIV portfolio that more than quintupled global sales in 5 years. Responsibility for global commercial strategy expanded to include clinical development.

Restructured and reorganized the company to deal with eroding market position and government health care reform. Chaired industry association.

Tripled area sales and raised market rank 3 places in 3 years.

Led international division's pharmaceutical business covering 6 therapeutic areas, including a global launch and roll-out of clarythromycin.

Mba, Marketing

Ba, History